Metabolic disorders including hypertension, dyslipidemia, obesity and diabetes reflect a complex tangle of interfaces with the microbiota representing only one part of the multiple factors at play.
This article explores the food, dietary supplement and drug pathways to market, including how to leverage clinical research and regulatory strategy for market success.
Personalized nutrition is an idea on the cusp of the mainstream. Yet, there is still work to do if personalized nutrition is to go mainstream and dispel doubts that it may be more hype than hard science.
Joint discomfort is a major problem. There is a need for therapies that manage minor pain without side effects. Perluxan could meet this therapeutic need.
Heart disease is a rare case of a big problem with a clear solution: Lower LDL. In Pantesin, manufacturers have an ingredient with a 40-year history of doing just that.
Content provided BY InterHealth Nutraceuticals, Inc.
Joint relief has traditionally been a profitability powerhouse, but recently the sector has slumped. Now, data suggest its salvation may lie in an ingredient: UC-II.
If the cognition market is to come to represent a proportion of the overall supplement market that is more indicative of the importance of brain health, ingredient suppliers must provide manufacturers with indisputable data demonstrating the efficacy...
Multiple studies indicate that a collagen-based dietary supplement regime can be an essential ingredient for promoting connective tissue health in skin and joints
